Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas

NCT03187210 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

20

Enrollment

OTHER

Sponsor class

Stopped low accrual

Conditions

Lymphoma

Interventions

DRUG: Brentuximab Vedotin
DRUG: BeEAM Regimen

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]